Gefitinib Ratiopharm

Gefitinib Ratiopharm is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Ratiopharm is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC where other treatments have failed.

Common effects of Gefitinib Ratiopharm may include skin rash, diarrhea, and fatigue. Some users might experience nausea or loss of appetite. These effects can vary from person to person and are not exhaustive. Always consult a healthcare provider for personalized advice.

Gefitinib Ratiopharm should be handled with care, especially by those with pre-existing medical conditions. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Gefitinib Ratiopharm may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of this medication. Always consult a healthcare provider before starting or stopping any medication.